{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:43:41Z","timestamp":1764377021406},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,27]]},"DOI":"10.7759\/cureus.10064","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T07:00:31Z","timestamp":1598511631000},"source":"Crossref","is-referenced-by-count":10,"title":["One-Year Follow-Up Study of Changes in Prostaglandin-Associated Periorbital Syndrome After Switch From Conventional Prostaglandin F2alfa to Omidenepag Isopropyl"],"prefix":"10.7759","author":[{"given":"Satomi","family":"Oogi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Nakakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuko","family":"Terao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Tabuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Kiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62347-3","article-title":"Glaucoma treatment: by the highest level of evidence","volume":"385","author":"Heijl A","year":"2015","unstructured":"Heijl A. Glaucoma treatment: by the highest level of evidence. Lancet. 2015, 385:1264-1266. 10.1016\/S0140-6736(14)62347-3","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62111-5","article-title":"Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial","volume":"385","author":"Garway-Heath DF","year":"2015","unstructured":"Garway-Heath DF, Crabb DP, Bunce C, et al.. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet. 2015, 385:1295-304. 10.1016\/S0140-6736(14)62111-5","journal-title":"Lancet"},{"key":"ref3","unstructured":"Prostaglandin-associated periorbitopathy. a postmarketing surveillance observation. (2011). https:\/\/glaucomatoday.com\/articles\/2011-june\/prostaglandin-associated-periorbitopathy?c4src=issue:feed."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.12163","article-title":"Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost","volume":"42","author":"Kucukevcilioglu M","year":"2014","unstructured":"Kucukevcilioglu M, Bayer A, Uysal Y, Altinsoy HI. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost. Clin Exp Ophthalmol. 2014, 42:126-131. 10.1111\/ceo.12163","journal-title":"Clin Exp Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0b013e31829d8dd7","article-title":"Latanoprost-induced prostaglandin-associated periorbitopathy","volume":"90","author":"Tan J","year":"2013","unstructured":"Tan J, Berke S. Latanoprost-induced prostaglandin-associated periorbitopathy. Optom Vis Sci. 2013, 90:245-247. 10.1097\/OPX.0b013e31829d8dd7","journal-title":"Optom Vis Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S75651","article-title":"Prostaglandin-associated periorbitopathy in latanoprost users","volume":"9","author":"Nakakura S","year":"2014","unstructured":"Nakakura S, Yamamoto M, Terao E, et al.. Prostaglandin-associated periorbitopathy in latanoprost users. Clin Ophthalmol. 2014, 9:51-56. 10.2147\/OPTH.S75651","journal-title":"Clin Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061638","article-title":"A cross-sectional survey of the association between bilateral topical prostaglandin analogue use and ocular adnexal features","volume":"8","author":"Shah M","year":"2013","unstructured":"Shah M, Lee G, Lefebvre DR, et al.. A cross-sectional survey of the association between bilateral topical prostaglandin analogue use and ocular adnexal features. PLoS One. 2013, 8:61638. 10.1371\/journal.pone.0061638","journal-title":"PLoS One"},{"key":"ref8","article-title":"Bimatoprost-induced chemical blepharoplasty","volume":"14","author":"Sarnoff DS","year":"2015","unstructured":"Sarnoff DS, Gotkin RH. Bimatoprost-induced chemical blepharoplasty. J Drugs Dermatol. 2015, 14:472-477.","journal-title":"J Drugs Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2020.06.003","article-title":"Omidenepag isopropyl versus latanoprost in primary open-angle glaucoma and ocular hypertension: the phase 3 AYAME study","volume":"[Epub ahead of print]","author":"Aihara M","year":"2020","unstructured":"Aihara M, Lu F, Kawata H, Iwata A, Odani-Kawabata N, Shams NK. Omidenepag isopropyl versus latanoprost in primary open-angle glaucoma and ocular hypertension: the phase 3 AYAME study. Am J Ophthalmol. 2020, [Epub ahead of print]:10.1016\/j.ajo.2020.06.003","journal-title":"Am J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-020-00748-x","article-title":"Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-\/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study","volume":"64","author":"Aihara M","year":"2020","unstructured":"Aihara M, Ropo A, Lu F, Kawata H, Iwata A, Odani-Kawabata N, Shams N. Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-\/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study. Jpn J Ophthalmol. 2020, 64:398-406. 10.1007\/s10384-020-00748-x","journal-title":"Jpn J Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000001442","article-title":"Changes in prostaglandin-associated periorbital syndrome after switch from conventional prostaglandin F2\u03b1 treatment to omidenepag isopropyl in 11 consecutive patients","volume":"29","author":"Nakakura S","year":"2020","unstructured":"Nakakura S, Terao E, Fujisawa Y, Tabuchi H, Kiuchi Y. Changes in prostaglandin-associated periorbital syndrome after switch from conventional prostaglandin F2\u03b1 treatment to omidenepag isopropyl in 11 consecutive patients. J Glaucoma. 2020, 29:326-328. 10.1097\/IJG.0000000000001442","journal-title":"J Glaucoma"},{"key":"ref12","unstructured":"Declaration of Helsinki. (2020). Accessed. April 8, 2020: https:\/\/www.wma.net\/what-we-do\/medical-ethics\/declaration-of-helsinki\/."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e31824d8d7c","article-title":"Deepening of the upper eyelid sulcus caused by 5 types of prostaglandin analogs","volume":"22","author":"Inoue K","year":"2013","unstructured":"Inoue K, Shiokawa M, Wakakura M, Tomita G. Deepening of the upper eyelid sulcus caused by 5 types of prostaglandin analogs. J Glaucoma. 2013, 22:626-631. 10.1097\/IJG.0b013e31824d8d7c","journal-title":"J Glaucoma"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-010-0904-z","article-title":"Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost","volume":"55","author":"Park J","year":"2011","unstructured":"Park J, Cho HK, Moon JI. Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost. Jpn J Ophthalmol. 2011, 55:22-27. 10.1007\/s10384-010-0904-z","journal-title":"Jpn J Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.6433","article-title":"Prostaglandin F2alpha receptor (FP receptor) agonists are potent adipose differentiation inhibitors for primary culture of adipocyte precursors in defined medium","volume":"233","author":"Serrero G","year":"1997","unstructured":"Serrero G, Lepak NM. Prostaglandin F2alpha receptor (FP receptor) agonists are potent adipose differentiation inhibitors for primary culture of adipocyte precursors in defined medium. Biochem Biophys Res Commun. 1997, 233:200-202. 10.1006\/bbrc.1997.6433","journal-title":"Biochem Biophys Res Commun"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.4.1855","article-title":"Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma","volume":"273","author":"Reginato MJ","year":"1998","unstructured":"Reginato MJ, Krakow SL, Bailey ST, Lazar MA. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma. J Biol Chem. 1998, 273:1855-1858. 10.1074\/jbc.273.4.1855","journal-title":"J Biol Chem"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-12589","article-title":"Activation of the prostanoid FP receptor inhibits adipogenesis leading to deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy","volume":"55","author":"Taketani Y","year":"2014","unstructured":"Taketani Y, Yamagishi R, Fujishiro T, Igarashi M, Sakata R, Aihara M. Activation of the prostanoid FP receptor inhibits adipogenesis leading to deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy. Invest Ophthalmol Vis Sci. 2014, 55:1269-1276. 10.1167\/iovs.13-12589","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2019.0079","article-title":"Effects of the selective EP2 receptor agonist omidenepag on adipocyte differentiation in 3T3-L1 cells","volume":"36","author":"Yamamoto Y","year":"2020","unstructured":"Yamamoto Y, Taniguchi T, Inazumi T, et al.. Effects of the selective EP2 receptor agonist omidenepag on adipocyte differentiation in 3T3-L1 cells. J Ocul Pharmacol Ther. 2020, 36:162-169. 10.1089\/jop.2019.0079","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref19","article-title":"Cilia Incarnata","author":"Patel BC","year":"2020","unstructured":"Patel BC, Malhotra R. Cilia Incarnata. StatPearls Publishing [Internet], Treasure Island (FL); 2020."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2020.0003","article-title":"The antiglaucoma agent and EP2 receptor agonist omidenepag does not affect eyelash growth in mice","volume":"[Epub ahead of print]","author":"Esaki Y","year":"2020","unstructured":"Esaki Y, Katsuta O, Kamio H, et al.. The antiglaucoma agent and EP2 receptor agonist omidenepag does not affect eyelash growth in mice. J Ocul Pharmacol Ther. 2020, [Epub ahead of print]:10.1089\/jop.2020.0003","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.05.041","article-title":"Clinical course of bimatoprost-induced periocular skin changes in Caucasians","volume":"113","author":"Doshi M","year":"2006","unstructured":"Doshi M, Edward DP, Osmanovic S. Clinical course of bimatoprost-induced periocular skin changes in Caucasians. Ophthalmology. 2006, 113:1961-1967. 10.1016\/j.ophtha.2006.05.041","journal-title":"Ophthalmology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096249","article-title":"Cross-sectional study of the association between a deepening of the upper eyelid sulcus-like appearance and wide-open eyes","volume":"9","author":"Nakakura S","year":"2014","unstructured":"Nakakura S, Terao E, Nagatomi N, Matsuo N, Shimizu Y, Tabuchi H, Kiuchi Y. Cross-sectional study of the association between a deepening of the upper eyelid sulcus-like appearance and wide-open eyes. PLoS One. 2014, 9:96249. 10.1371\/journal.pone.0096249","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/38221-one-year-follow-up-study-of-changes-in-prostaglandin-associated-periorbital-syndrome-after-switch-from-conventional-prostaglandin-f2alfa-to-omidenepag-isopropyl","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:21:28Z","timestamp":1707506488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/38221-one-year-follow-up-study-of-changes-in-prostaglandin-associated-periorbital-syndrome-after-switch-from-conventional-prostaglandin-f2alfa-to-omidenepag-isopropyl"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.10064","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,27]]}}}